Medtronic and Medtronic Foundation Partner to Address COVID-19 Surges with Focus on Equity

 
 

- Medtronic plc (NYSE:MDT) and the Medtronic Foundation announced an additional $3M USD for COVID-19 relief efforts a combination of financial resources, personal protective equipment (PPE) donations, and Medtronic employee engagement focused on underserved areas of India Brazil the United States and other global regions. This latest COVID-19 response expands Medtronic and Medtronic Foundation's COVID-19 support to $56M USD .

 

The Medtronic Foundation is partnering with established nonprofit organizations already on the ground and actively working with communities to combat the COVID-19 surges. These new resources aim to:

 
  • Provide medical supplies and equipment such as personal protective equipment (PPE) and oxygen concentrators.
  •  
  • Supply temporary COVID-19 treatment sites and quarantine facilities.
  •  
  • Train frontline health workers, providing coronavirus health education.
  •  
  • Address vaccine hesitancy to prevent a third surge.
  •  

"The overwhelming surge of record-breaking COVID-19 cases and deaths in communities around the world show us how the pandemic exacerbates the social, economic, and health inequities for underserved communities," said Paurvi Bhatt , Medtronic Foundation president. "Together with our nonprofit partners and Medtronic employees, we are focusing this phase of our COVID-19 response on communities in immediate need of care and vaccines in India , Brazil , and the United States to enable more equitable access so people have an opportunity to survive this devastating pandemic."

 

   Engaging Together
 
In addition to financial support to nonprofit partners and facilitating product donations, the Medtronic Foundation is matching 2:1 Medtronic employee and retiree donations to eligible nonprofit organizations worldwide and to the Medtronic Employee Emergency Assistance Fund (MEEAF) to support Medtronic employees and their families impacted by COVID-19.

 

For the 90,000+ global Medtronic employees, the Medtronic Foundation also is organizing virtual volunteer opportunities to support non-profit organizations responding to the COVID-19 surges include serving as vaccine ambassadors and training healthcare workers in underserved areas.

 

   About Medtronic Foundation
 
Medtronic plc is the sole funder of Medtronic Foundation, whose focus is on improving lives for underserved populations worldwide, as well as supporting communities in which Medtronic employees live and give. For more information, please visit   medtronicfoundation.org   .

 

   About Medtronic
 
Medtronic plc (   www.medtronic.com   ), headquartered in Dublin, Ireland , is among the world's largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

 

  Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.  

 
 
                      
 

   Contacts:   

 
 
 
 
 

  Elizabeth Costello  

 
 

  John Jordan  

 
 

  Medtronic Foundation  

 
 

  Medtronic  

 
 

  Public Relations  

 
 

  Public Relations  

 
 

  +1-612-940-7693  

 
 

  +1-508-452-4891  

 
 
 
 

  Ryan Weispfenning  

 
 
 

  Medtronic  

 
 
 

  Investor Relations  

 
 
 

  +1-763-505-4626  

 
 
 
 

 

 
 

  (PRNewsfoto/Medtronic plc) 

 
 

 

 
 
 

 Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/medtronic-and-medtronic-foundation-partner-to-address-covid-19-surges-with-focus-on-equity-301290496.html  

 

SOURCE Medtronic plc

 
 

News Provided by PR Newswire via QuoteMedia

The Conversation (0)
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians.

BlinkLab states in its Wednesday (March 12) release that the study is the largest digital diagnostic trial for autism in the US, with its aim being to support the early detection of developmental conditions like autism.

The first patient test took place at PriMED Clinical Research in Dayton, Ohio. PriMED, a division of PriMED Physicians, is one of two clinical sites selected for the study’s initial phase, which is targeting 100 patients.

Keep reading...Show less
HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Limited (ASX: HMD), a medical data and technology company leading the digital transformation of maternity care, is delighted to announce it has entered into a collaboration agreement with Garmin (NYSE: GRMN), a leading global provider of smartwatches and GPS-enabled products, aimed at enhancing remote pregnancy monitoring and expanding the range of health data available to expectant mothers and their healthcare providers.

Keep reading...Show less
Cardiologist wearing virtual reality glasses.

2 Biggest Medical Device ETFs in 2025

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.

Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or a mix of both. Aside from stocks, some ETFs also track commodities or bonds.

In the healthcare industry, medical device ETFs bring together companies that go to great lengths to develop pharmaceutical-based technology that can improve the lives of patients.

Keep reading...Show less
Cyclomedica

Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare (HCA), one of the largest single healthcare providers in the United States. This agreement marks a significant milestone for the company which will allow the deployment of Technegas® in up to 169 nuclear medicine departments across HCA’s extensive network.1

Keep reading...Show less
CONNEQT App Launches in USA as Pulse Deliveries Commence

CONNEQT App Launches in USA as Pulse Deliveries Commence

Cardiex Limited (CDX:AU) has announced CONNEQT App Launches in USA as Pulse Deliveries Commence

Download the PDF here.

Female doctor with clipboard talking to smiling female patient at hospital.

Revolutionizing Women's Health: Antifungal Innovation Brings New Investment Opportunities

The intersection of women's health and antifungal innovation represents a pivotal moment in healthcare, offering both transformative medical advancements and compelling investment opportunities.

The groundbreaking developments in antifungal treatments specifically targeting women's health issues present a substantial market potential, resulting in rising investor interest in this rapidly evolving sector.

Despite comprising half the global population, women face unique health challenges that have historically received insufficient attention and investment. Among these health challenges, vaginal candidiasis stands out as a persistent and widespread issue affecting millions of women worldwide.

Keep reading...Show less

Latest Press Releases

Related News

×